vertebroplasty needles market size, vertebroplasty needles industry trends, vertebroplasty needles market growth, vertebroplasty needles market share, vertebroplasty needles market insights, vertebroplasty needles market
What is the present valuation and projected CAGR of the vertebroplasty needles market?
The vertebroplasty needles market size has grown rapidly in recent years. It will grow from $1 billion in 2024 to $1.13 billion in 2025 at a compound annual growth rate (CAGR) of 13.0%. The growth in the historic period can be attributed to an aging population, advancements in minimally invasive techniques, raising awareness, increasing healthcare expenditure, the expansion of healthcare infrastructure, and government support and funding.
The vertebroplasty needles market size is expected to see rapid growth in the next few years. It will grow to $1.81 billion in 2029 at a compound annual growth rate (CAGR) of 12.7%. The growth in the forecast period can be attributed to an increasing incidence of osteoporosis, a growing preference for minimally invasive surgeries, expansion in emerging markets, an aging global population, rising healthcare spending, and increasing professional training. Major trends in the forecast period include technological integration, innovation in needle design, AI and machine learning, personalized medicine, telemedicine integration, robotics and automation, and sustainability initiatives.
Get Your Free Sample of The Global Vertebroplasty Needles Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=17292&type=smp
What key drivers have fueled the vertebroplasty needles market’s development over the years?
An increase in the number of spine injuries is expected to propel the growth of the vertebroplasty needles market going forward. Spine injuries refer to any damage or trauma to the spinal cord, vertebrae, or surrounding tissues, which can result in pain, loss of mobility, or paralysis. Spine injuries are on the rise, driven by factors such as aging populations, increasing participation in sports, and the prevalence of motor vehicle accidents. Vertebroplasty needles are crucial for stabilizing spine injuries by precisely injecting bone cement into fractured vertebrae to alleviate pain and restore vertebral strength. For instance, in May 2024, according to the Spinal Injuries Association, a US-based organization in the field of spinal cord injury care, there were approximately 4,400 new cases of spinal cord injury annually in the UK, translating to someone becoming paralyzed every two hours, leading to an estimated total prevalence of 105,000 spinal cord injuries in 2024. Therefore, an increasing number of spine injuries is driving the vertebroplasty needles market.
What is the segmentation for the vertebroplasty needles market?
The vertebroplasty needles market covered in this report is segmented –
1) By Type: 2.5×100, 2.5×130, 3.2×100, 3.2×130
2) By Product Type: Bone Cement Needles, Aspiration Needles
3) By Procedure Type: Percutaneous Vertebroplasty, Kyphoplasty
Subsegments
1) By 2.5×100: Single Use 2.5×100 Needle, Reusable 2.5×100 Needle
2) By 2.5×130: Single Use 2.5×130 Needle, Reusable 2.5×130 Needle
3) By 3.2×100: Single Use 3.2×100 Needle, Reusable 3.2×100 Needle
4) By 3.2×130: Single Use 3.2×130 Needle, Reusable 3.2×130 Needle
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/vertebroplasty-needles-global-market-report
Who are the most influential companies in the vertebroplasty needles market?
Major companies operating in the vertebroplasty needles market are Medtronic plc, Becton Dickinson and Company, Stryker Corporation, DePuy Synthes Inc, Cook Medical LLC, Merit Medical Systems Inc., Globus Medical Inc., Argon Medical Devices Inc., Amplitude Surgical SAS, OptiMed GmbH, Tecres S.p.A, Zavation Medical Products LLC, Auxein Medical Pvt Ltd, Captiva Spine Inc., Laurane Medical LLC, Osseon Technologies, Adroit Manufacturing Co., BIOPSYBELL S.R.L., Surtech Medical Inc., TAEYEON Medical Co. Ltd., Teknimed S A S
What are the top industry trends projected to impact the vertebroplasty needles market?
Major companies operating in the vertebroplasty needles market are focusing on developing innovative technologies such as regenerative biomaterials to enhance the effectiveness of spinal treatments, improve patient outcomes, and reduce recovery times. Regenerative biomaterials refer to materials engineered to support the repair and regeneration of damaged tissues by mimicking the natural extracellular matrix. For instance, in November 2022, RevBio, a US-based clinical-stage medical device company, launched an experiment to test its regenerative biomaterial, Tetranite. Tetranite is an injectable bone adhesive that has significant implications for vertebroplasty and related procedures. The material can bond bone fragments together and fill voids, providing immediate stability during the healing process. This capability is crucial in vertebroplasty, where stabilizing fractured vertebrae is essential for recovery.
What are the major regional insights for the vertebroplasty needles market, and which region holds the top position?
North America was the largest region in the vertebroplasty needles market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the vertebroplasty needles market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Vertebroplasty Needles Market Report 2025 Offer?
The vertebroplasty needles market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
A vertebroplasty needle is a specialized medical instrument used in the minimally invasive surgical procedure known as vertebroplasty. This procedure is typically performed to treat compression fractures in the spine, often caused by osteoporosis or trauma. The needle is used to inject bone cement (usually a type of acrylic resin) directly into the fractured vertebra under imaging guidance, such as fluoroscopy or a computed tomography scan (CT scan), to stabilize the bone and relieve pain. The needle is designed to be precise and minimally traumatic to surrounding tissues during the cement injection process.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=17292
About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
